Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Burton G. Malkiel currently holds 100,589 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Burton G. Malkiel has been a net buyer of TBPH stock. They have purchased $889.4K and sold $0 worth of shares.
Burton G. Malkiel's most recent insider trade was on May 2, 2023, when they sold 9,132 shares at $0.00 per share.
Burton G. Malkiel serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 22 insider transactions totaling $889.4K over their tenure at the company.
Burton G. Malkiel holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Burton G. Malkiel has shown a buying trading pattern, with $889.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Burton G. Malkiel was on Aug 11, 2017, when they purchased $368.9K worth of TBPH shares. This transaction involved 15,000 shares at $24.59 per share.
Burton G. Malkiel currently owns 100,589 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Burton G. Malkiel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Burton G. Malkiel has 22 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Burton G. Malkiel and 40,000+ other insiders.